Depression and Anxiety Trial, Recruiting (NCT05921201)

Depression and Anxiety Trial, Recruiting NCT05921201 Sponsor: Northeastern University Condition: Depression and Anxiety

Printed from Voxsanity (voxsanity.com.au) — NCT05921201 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Depression And Anxiety

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of ethnic Chinese descent who were born in or grew up in the United States (sometimes called Chinese Americans), living in the Greater Boston Area in Massachusetts
People aged 14 to 18 years old who are currently enrolled in school
People who are able to read and understand at around a sixth-grade reading level
People who are willing and able to sign a consent or assent form agreeing to take part

Who may not be able to join:

People whose reading level is below sixth grade, as the tasks in the study require this level of understanding
People who have been diagnosed with major depression or another mental health condition that would require more intensive treatment than this program is designed to provide
People who score 3 or above on two short mental health screening questionnaires (called the PHQ-2 and GAD-2), as this may indicate a need for more support than this program can offer (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Chieh Li, EdD, Northeastern University

Phone: 6173734683

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05921201

Sponsor: Northeastern University

Phase: Not Applicable

Status: Recruiting

Condition: Depression and Anxiety

Trial contact: 6173734683

More information: https://clinicaltrials.gov/study/NCT05921201

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of ethnic Chinese descent who were born in or grew up in the United States (sometimes called Chinese Americans), living in the Greater Boston Area in Massachusetts
People aged 14 to 18 years old who are currently enrolled in school
People who are able to read and understand at around a sixth-grade reading level
People who are willing and able to sign a consent or assent form agreeing to take part

Who may not be able to join:

People whose reading level is below sixth grade, as the tasks in the study require this level of understanding
People who have been diagnosed with major depression or another mental health condition that would require more intensive treatment than this program is designed to provide
People who score 3 or above on two short mental health screening questionnaires (called the PHQ-2 and GAD-2), as this may indicate a need for more support than this program can offer (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Northeastern University

Registry

ClinicalTrials.gov

Start date

25 March 2024

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient Health Questionnaire 9 (PHQ-9)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov